ApabetaloneApabetalone (development codes RVX 208, RVX-208, and RVX000222) is an orally available small molecule created by Resverlogix Corp. that is being evaluated in clinical trials for the treatment of atherosclerosis and associated cardiovascular disease (CVD). Read from the Chembox of the Wikipedia article Apabetalone, revision 1379976868.

Property

Value

Formula

C20H22N2O5, 370.40 g/mol

Density

1.3 g/cm³

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.